Grading quality of evidence and strength of recommendations
- PMID:15205295
- PMCID: PMC428525
- DOI: 10.1136/bmj.328.7454.1490
Grading quality of evidence and strength of recommendations
Abstract
Users of clinical practice guidelines and other recommendations need to know how much confidence they can place in the recommendations. Systematic and explicit methods of making judgments can reduce errors and improve communication. We have developed a system for grading the quality of evidence and the strength of recommendations that can be applied across a wide range of interventions and contexts. In this article we present a summary of our approach from the perspective of a guideline user. Judgments about the strength of a recommendation require consideration of the balance between benefits and harms, the quality of the evidence, translation of the evidence into specific circumstances, and the certainty of the baseline risk. It is also important to consider costs (resource utilisation) before making a recommendation. Inconsistencies among systems for grading the quality of evidence and the strength of recommendations reduce their potential to facilitate critical appraisal and improve communication of these judgments. Our system for guiding these complex judgments balances the need for simplicity with the need for full and transparent consideration of all important issues.
Similar articles
- The future of Cochrane Neonatal.Soll RF, Ovelman C, McGuire W.Soll RF, et al.Early Hum Dev. 2020 Nov;150:105191. doi: 10.1016/j.earlhumdev.2020.105191. Epub 2020 Sep 12.Early Hum Dev. 2020.PMID:33036834
- Systems for grading the quality of evidence and the strength of recommendations II: pilot study of a new system.Atkins D, Briss PA, Eccles M, Flottorp S, Guyatt GH, Harbour RT, Hill S, Jaeschke R, Liberati A, Magrini N, Mason J, O'Connell D, Oxman AD, Phillips B, Schünemann H, Edejer TT, Vist GE, Williams JW Jr; GRADE Working Group.Atkins D, et al.BMC Health Serv Res. 2005 Mar 23;5(1):25. doi: 10.1186/1472-6963-5-25.BMC Health Serv Res. 2005.PMID:15788089Free PMC article.
- Grading quality of evidence and strength of recommendations in clinical practice guidelines. Part 1 of 3. An overview of the GRADE approach and grading quality of evidence about interventions.Brozek JL, Akl EA, Alonso-Coello P, Lang D, Jaeschke R, Williams JW, Phillips B, Lelgemann M, Lethaby A, Bousquet J, Guyatt GH, Schünemann HJ; GRADE Working Group.Brozek JL, et al.Allergy. 2009 May;64(5):669-77. doi: 10.1111/j.1398-9995.2009.01973.x.Allergy. 2009.PMID:19210357Review.
- [The GRADE System. An international approach to standardize the graduation of evidence and recommendations in guidelines].Kunz R, Burnand B, Schünemann HJ; Grading of Recommendations, Assessment, Development and Evaluation (GRADE) Working Group.Kunz R, et al.Internist (Berl). 2008 Jun;49(6):673-80. doi: 10.1007/s00108-008-2141-9.Internist (Berl). 2008.PMID:18461295German.
- Moving from evidence to developing recommendations in guidelines: article 11 in Integrating and coordinating efforts in COPD guideline development. An official ATS/ERS workshop report.Schünemann HJ, Oxman AD, Akl EA, Brozek JL, Montori VM, Heffner J, Hill S, Woodhead M, Campos-Outcalt D, Alderson P, Woitalla T, Puhan MA, Falck-Ytter Y, Bousquet J, Guyatt G; ATS/ERS Ad Hoc Committee on Integrating and Coordinating Efforts in COPD Guideline Development.Schünemann HJ, et al.Proc Am Thorac Soc. 2012 Dec;9(5):282-92. doi: 10.1513/pats.201208-064ST.Proc Am Thorac Soc. 2012.PMID:23256172Review.
Cited by
- Sodium-glucose cotransporter-2 inhibitors in acute myocardial infarction: a systematic review and meta-analysis of randomized controlled trials.Coelho Meine M, Santo P, Dolovitsch de Oliveira F, Lenci Marques G, Spadoni Barboza J.Coelho Meine M, et al.Heart Fail Rev. 2025 Jan;30(1):219-226. doi: 10.1007/s10741-024-10457-z. Epub 2024 Oct 29.Heart Fail Rev. 2025.PMID:39467963Review.
- Which health technologies should be funded? A prioritization framework based explicitly on value for money.Golan O, Hansen P.Golan O, et al.Isr J Health Policy Res. 2012 Nov 26;1(1):44. doi: 10.1186/2045-4015-1-44.Isr J Health Policy Res. 2012.PMID:23181391Free PMC article.
- The Hospital Frailty Risk Score (HFRS) applied to primary data: protocol for a systematic review.Alshibani A, Warner B, Owen RK, Mukherjee A, Gilbert T, Conroy S.Alshibani A, et al.BMJ Open. 2022 Oct 19;12(10):e065499. doi: 10.1136/bmjopen-2022-065499.BMJ Open. 2022.PMID:36261239Free PMC article.
- Twenty-four-hour ambulatory blood pressure monitoring in hypertension: an evidence-based analysis.Health Quality Ontario.Health Quality Ontario.Ont Health Technol Assess Ser. 2012;12(15):1-65. Epub 2012 May 1.Ont Health Technol Assess Ser. 2012.PMID:23074425Free PMC article.Review.
- Chronic obstructive pulmonary disease (COPD) evidentiary framework.OHTAC COPD Collaborative.OHTAC COPD Collaborative.Ont Health Technol Assess Ser. 2012;12(2):1-97. Epub 2012 Mar 1.Ont Health Technol Assess Ser. 2012.PMID:23074430Free PMC article.Review.No abstract available.
References
- Sackett DL. Rules of evidence and clinical recommendations on the use of antithrombotic agents. Chest 1986;89(suppl 2): 2-3S. - PubMed
- Sackett DL. Rules of evidence and clinical recommendations on the use of antithrombotic agents. Arch Intern Med 1986:146: 464-5. - PubMed
- Sackett DL. Rules of evidence and clinical recommendations on the use of antithrombotic agents. Chest 1989;95: 2-4S. - PubMed
- Cook DJ, Guyatt GH, Laupacis A, Sackett DL. Rules of evidence and clinical recommendations on the use of antithrombotic agents. Antithrombotic therapy consensus conference. Chest 1992;102(suppl 4): 305-11S. - PubMed
Publication types
MeSH terms
Related information
LinkOut - more resources
Full Text Sources